A polypill strategy to improve global secondary cardiovascular prevention

August 4, 2014, American College of Cardiology
This Central Illustration for the article shows adherence to the polypill compared to usual care with multiple pills extracted from published research studies, and identifies reasons patients fail to take medications prescribed for secondary prevention of heart disease. Credit: Journal of the American College of Cardiology. 2014;64(6):613-621

The polypill, a combination pill taken just once a day that includes key medications for secondary prevention of heart disease, may be an effective low-cost strategy to improve adherence to medication recommendations and reduce costs, according to researchers from Spain and New York, who reviewed research on the polypill.

The review article, A Polypill Strategy to Improve Global Secondary Cardiovascular Prevention, was published online today in the Journal of the American College of Cardiology and will appear in the August 12, 2014 print issue.

Cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year. As the population ages and patients with survive longer, a growing pool of patients could benefit from secondary prevention of heart disease.

Secondary prevention includes lifestyle changes and the use of medications—including statins, medications to reduce blood pressure, and antithrombotic agents. Use of these medications, which are generally low cost and safe, is thought to be responsible for half of the overall 50 percent reduction in mortality from heart disease in the past 20 years in some Western countries.

According to the researchers, there is room for improvement in secondary prevention, especially in nations with limited resources. The polypill, a taken just once a day that includes key medications for of heart disease, has been proposed as a low-cost strategy to improve adherence and reduce costs.

Explore further: Largest ever analysis on the use of a polypill in cardiovascular disease

More information: Journal of the American College of Cardiology, dx.doi.org/10.1016/j.jacc.2014.06.009

Related Stories

Largest ever analysis on the use of a polypill in cardiovascular disease

May 7, 2014
New data presented for the first time at the World Heart Federation's World Congress of Cardiology 2014 shows a significant improvement in both patient adherence and risk factor control when patients at high risk of heart ...

Evidence points to potential benefits of polypill for heart health

April 21, 2014
(Medical Xpress)—Taking one pill instead of three could be a powerful ally to prevent cardiovascular disease, according to a new Cochrane systematic review of the latest research on polypills from a team of scientists at ...

Multi-drug pills help people stick to heart disease prevention regimens

September 3, 2013
People are much more likely to take preventive medicines if they're combined in one pill, an international study has found. The findings are published today in the Journal of the American Medical Association.

People more likely to take heart medicines in combo pill

November 6, 2012
People are much more likely to take heart medicines if they're combined in one pill, according to a late-breaking clinical trial presented at the American Heart Association's Scientific Sessions 2012.

International trial finds polypill halves predicted heart disease and stroke risk

May 25, 2011
The world's first international polypill trial has shown that a four-in-one combination pill can halve the predicted risk of heart disease and stroke. The results are published online today in the open access journal PLoS ...

Recommended for you

Biomechanical mapping method aids development of therapies for damaged heart tissue

January 23, 2018
Researchers have developed a new way to capture the detailed biomechanical properties of heart tissue. The high-resolution optical technique fills an important technology gap necessary to develop and test therapies that might ...

Researchers borrow from AIDS playbook to tackle rheumatic heart disease

January 22, 2018
Billions of US taxpayer dollars have been invested in Africa over the past 15 years to improve care for millions suffering from the HIV/AIDS epidemic; yet health systems on the continent continue to struggle. What if the ...

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.